✦ LIBER ✦

Long-term outcomes after nucleos(t)ide analogues discontinuation in chronic hepatitis B patients with HBeAg-negative

✍ Scribed by He, Dengming; Guo, Shimin; Chen, Wen; Chen, Xianli; Yan, Guohua; Wang, Jie; Li, Maoshi; Zhu, Peng; Huang, Hongfei; Wang, Yuming

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P1096 LONG-TERM OUTCOMES AFTER NUCLEOS(T

✍ He, D.; Tao, S.; Guo, S.; Wang, Y.; Ding, M. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Treatment of HBeAg-negative chronic hepa

✍ George V. Papatheodoridis 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB

Why do I treat HBeAg-negative chronic he

✍ Papatheodoridis, George V. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

HBeAg-negative chronic hepatitis B: why

✍ Pietro Lampertico; Massimo Colombo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Su1018 Discontinuation of Long-Term Nucl

✍ Manolakopoulos, Spilios; Kranidioti, Hariklia; Deutsch, Melanie; Alexopoulou, Al 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Can Nucleos(t)ide Analogue (NA) Therapy

✍ Hadziyannis, Stephanos J.; Vassilopoulos, Dimitrios; Sevastianos, Vassilios; Had 📂 Article 📅 2014 🏛 Current Science Inc. 🌐 English ⚖ 277 KB